679 related articles for article (PubMed ID: 28319564)
1. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
[TBL] [Abstract][Full Text] [Related]
2. Improved posttransplant mortality after share 35 for liver transplantation.
Kwong AJ; Goel A; Mannalithara A; Kim WR
Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
[TBL] [Abstract][Full Text] [Related]
3. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
[TBL] [Abstract][Full Text] [Related]
4. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP
Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
[TBL] [Abstract][Full Text] [Related]
5. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
[TBL] [Abstract][Full Text] [Related]
6. Improved retransplant outcomes: early evidence of the share35 impact.
Brooks JT; Koizumi N; Neglia E; Gdoura B; Wong TW; Kwon C; Smith TE; Ortiz J
HPB (Oxford); 2018 Jul; 20(7):649-657. PubMed ID: 29500002
[TBL] [Abstract][Full Text] [Related]
7. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
8. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
9. Liver sharing and organ procurement organization performance.
Gentry SE; Chow EK; Massie A; Luo X; Zaun D; Snyder JJ; Israni AK; Kasiske B; Segev DL
Liver Transpl; 2015 Mar; 21(3):293-9. PubMed ID: 25556648
[TBL] [Abstract][Full Text] [Related]
10. Liver Transplantation at Mayo Clinic Florida.
Lee DD; Croome KP; Perry DK; Burns JM; Nguyen JH; Keaveny AP; Taner CB
Clin Transpl; 2014; ():83-90. PubMed ID: 26281131
[TBL] [Abstract][Full Text] [Related]
11. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
[TBL] [Abstract][Full Text] [Related]
12. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
[TBL] [Abstract][Full Text] [Related]
13. Use of Elderly Allografts in Liver Transplantation.
Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
[TBL] [Abstract][Full Text] [Related]
14. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
[TBL] [Abstract][Full Text] [Related]
15. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
[TBL] [Abstract][Full Text] [Related]
17. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
Trotter JF; Osgood MJ
JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
[TBL] [Abstract][Full Text] [Related]
18. Improving Liver Allocation Using Optimized Neighborhoods.
Kilambi V; Mehrotra S
Transplantation; 2017 Feb; 101(2):350-359. PubMed ID: 27906775
[TBL] [Abstract][Full Text] [Related]
19. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
20. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
